Infekcyjne zapalenie wsierdzia u dzieci — wzrastający problem

Paczkowski, Konrad; Chojnicki, Maciej; Paczkowska, Katarzyna; Romanowicz, Anna; Gierat-Haponiuk, Katarzyna; Haponiuk, Ireneusz

doi:10.5603/fc.2019.0040

Cited by 2 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The process involves taking three blood cultures through separate venous punctures on the first day of fever. If there is no rise after two days of incubation, 2-3 more blood samples should be taken [15]. These cultures can most frequently identify Streptococcus viridans, Streptococcus bovis, Staphylococcus aureus, and microorganisms from the HACEK group (Haemophilus parainfluenzae, H. aphrophilus, H. paraphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium homi-nis, Eikenella corrodens, Kingellas, etc.).…”

Section: Microbiological Diagnosismentioning

confidence: 99%

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Cinteză

Vasile

et al. 2023

JCM

View full text Add to dashboard Cite

Infective endocarditis (IE) is a disease of the endocardium, which leads to the appearance of vegetation on the valves, cardiac structures, or, potentially, vascular endothelium of the heart. The risk of IE can be increased more than 140 times by congenital heart disease (50–59% of all IE), particularly if cyanotic. An increase in mortality may result from IE in patients with a complex cardiac pathology or patients with an implanted prosthetic material, most frequently conduits in a pulmonary position. Cardiac implantable electronic devices (CIED) infective endocarditis is a life-threatening complication representing 10% of all cases of endocarditis. Common signs of presentation are often fever and chills; redness and swelling at the pocket of the pacemaker, including the erosion and exteriorization of the device; and life-threatening sepsis. The use of intracardiac echocardiography for the diagnosis of IE is an innovative method. This may be needed, especially in older children undergoing complex cardiac surgery, when transthoracic echocardiography (TTE) and transesophageal echocardiography (TOE) failed to provide a reliable diagnosis. The 2018 European Heart Rhythm Association (EHRA) experts’ consensus statement on transvenous lead extraction recommends complete device removal and antimicrobial therapy for any device-related infection, including CIED-IE. The most detected microorganism was Staphylococcus Aureus. In addition, cardiac surgery and interventional cardiology associated with the placement of prostheses or conduits may increase the risk of IE up to 1.6% for Melody valve implantation. Our manuscript presents a comprehensive review of infective endocarditis associated with cardiac devices and prostheses in the pediatric population, including recent advances in diagnosis and management.

show abstract

Section: Microbiological Diagnosismentioning

confidence: 99%

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Cinteză

Vasile

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…choroba zastawkowa, pozostawiony przeciek) powoduje uszkodzenie śródbłonka, po którym następuje nagromadzenie w tym miejscu płytek krwi oraz fibryny co skutkuje powstaniem niebakteryjnego zakrzepowego zapalenia wsierdzia(NZZW). NZZW stanowi doskonałe miejsce do rozwoju bakterii oraz grzybów 7 . Białka adhezyny, takie jak białko wiążące fibronektynę oraz gronkowcowe czynniki zlepiania A i B są bakteryjnymi mediatorami przylegania i kluczowymi determinantami chorobotwórczości 8,9 .…”

Section: Patogenezaunclassified

Infective endocarditis - a challenge for modern medicine. Review

Dobrzyński

Czarnota

Skubel

et al. 2022

J Educ Health Sport

View full text Add to dashboard Cite

Infective endocarditis (IE) is defined by a focus of infection within the heart and is a feared disease across the field of cardiology. Prevalence varies from country to country, remaining in the range of 3-10/100 000 a year. Despite optimal care, mortality approaches 30% at 1 year. With an ageing population and increasing use of implantable cardiac devices and heart valves, the epidemiology of IE has changed. The microbiology of the disease has also changed, and staphylococci, most often associated with health-care contact and invasive procedures, have overtaken streptococci as the most common cause of the disease. The main lesions of IE are vegetations which cause emboli and destruction of valvular and/or perivalvular tissues leading to acute valvular regurgitations. Two main treatment pathways include antibiotic therapy and surgery The key to choosing the correct and most effective path is early diagnosis. The challenges posed by infective endocarditis are significant and therefore need further evaluation.

show abstract

Infekcyjne zapalenie wsierdzia u dzieci — wzrastający problem

Cited by 2 publications

References 23 publications

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Infective Endocarditis among Pediatric Patients with Prosthetic Valves and Cardiac Devices: A Review and Update of Recent Emerging Diagnostic and Management Strategies

Infective endocarditis - a challenge for modern medicine. Review

Contact Info

Product

Resources

About